These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3475538)

  • 41. Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment?
    White AA; Stevenson DD
    J Allergy Clin Immunol; 2010 Oct; 126(4):745-6. PubMed ID: 20920763
    [No Abstract]   [Full Text] [Related]  

  • 42. [Desensitization in drug hypersensitivity].
    Piotrowicz-Wójcik K; Porebski G; Czarnobilska E
    Przegl Lek; 2013; 70(12):1008-10. PubMed ID: 24720117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis of aspirin-exacerbated respiratory disease.
    Stevenson DD; Zuraw BL
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):169-88. PubMed ID: 12668897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspirin and NSAID sensitivity.
    Stevenson DD
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspirin desensitization in aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD
    Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of aspirin desensitization in the management of chronic rhinosinusitis.
    Rizk H
    Curr Opin Otolaryngol Head Neck Surg; 2011 Jun; 19(3):210-7. PubMed ID: 21372715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aspirin desensitization in aspirin-sensitive asthma: failure to maintain a desensitized state during prolonged therapy.
    Dankner RE; Wedner HJ
    Am Rev Respir Dis; 1983 Nov; 128(5):953-5. PubMed ID: 6638687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs.
    Laidlaw TM; Cahill KN
    J Allergy Clin Immunol Pract; 2017; 5(3):537-545. PubMed ID: 28483309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin intolerance and asthmal induction of a tolerance and long-term monitoring.
    Dor PJ; Vervloet D; Baldocchi G; Charpin J
    Clin Allergy; 1985 Jan; 15(1):37-42. PubMed ID: 3978776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified.
    Pérez-Alzate D; Cornejo-García JA; Pérez-Sánchez N; Andreu I; García-Moral A; Agúndez JA; Bartra J; Doña I; Torres MJ; Blanca M; Blanca-López N; Canto G
    J Investig Allergol Clin Immunol; 2017; 27(1):32-39. PubMed ID: 28211343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day].
    Gosepath J; Schäfer D; Mann WJ
    Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonsteroidal anti-inflammatory-induced inhibition of signal transducer and activator of transcription 6 (STAT-6) phosphorylation in aspirin-exacerbated respiratory disease.
    Katial RK; Martucci M; Burnett T; Faino A; Finkas L; Liu S; Alam R
    J Allergy Clin Immunol; 2016 Aug; 138(2):579-85. PubMed ID: 26915678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma.
    Settipane RA; Stevenson DD
    J Allergy Clin Immunol; 1989 Jul; 84(1):26-33. PubMed ID: 2666482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspirin therapy in aspirin-exacerbated respiratory disease: a risk-benefit analysis for the practicing allergist.
    Baker TW; Quinn JM
    Allergy Asthma Proc; 2011; 32(5):335-40. PubMed ID: 22195684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypersensitivity to aspirin and urgent percutaneous coronary intervention: A therapeutic challenge.
    Duarte T; Gonçalves S; Sá C; Marinheiro R; Rodrigues R; Seixo F; Tomas E; Caria R
    Rev Port Cardiol; 2016 Nov; 35(11):619.e1-619.e5. PubMed ID: 27717518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
    Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z
    J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspirin desensitisation for Chinese patients with coronary artery disease.
    Lee JK; Tsui KL; Cheung CY; Chau CH; Chan HL; Wu KL; Cheung GS; Choi MC; Chan KK; Li SK
    Hong Kong Med J; 2013 Jun; 19(3):207-13. PubMed ID: 23650199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
    Woessner KM; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies.
    White AA; Stevenson DD; Woessner KM; Simon RA
    Allergy Asthma Proc; 2013; 34(2):138-42. PubMed ID: 23484888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salsalate cross-sensitivity in aspirin-sensitive patients with asthma.
    Stevenson DD; Hougham AJ; Schrank PJ; Goldlust MB; Wilson RR
    J Allergy Clin Immunol; 1990 Nov; 86(5):749-58. PubMed ID: 2229840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.